MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0148
+0.0002 (+1.37%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close0.0146
Open0.0140
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0140 - 0.0149
52 Week Range0.0100 - 0.0800
Volume3,711,157
Avg. Volume7,523,210
Market Cap107.521M
Beta (5Y Monthly)-0.38
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateNov 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Medical Marijuana, Inc. CEO Featured in U.S. News and World Report Providing Insight on Penny Stocks

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus was featured in global financial news outlet U.S. News and World Report discussing his expertise in penny stocks.

  • HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors
    PR Newswire

    HempMeds®, Subsidiary of Medical Marijuana, Inc., Expands Popular CBD Oil Tincture Line with Two New Flavors

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has expanded its popular line of naturally flavored Dixie Botanicals® Dew Drops Cannabidiol (CBD) Oil Tinctures to include strawberry and tangerine.

  • PR Newswire

    Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.

  • Reuters

    CORRECTED-As customers hoard pot brownies, N.American weed firms see lockdown boost

    Cannabis sales are touching new highs as customers across the United States and Canada stockpile weed to prepare for long spells of isolation because of the coronavirus pandemic. Between March 16 and March 22, sales of recreational cannabis across key U.S. markets, including California, Colorado, Oregon and Alaska, were up 50% and medical marijuana sales rose 41% from the same period last year, figures obtained from cannabis point of sale and data platform Flowhub show. Several U.S. states and Canadian provinces have taken steps to curb the fast-spreading coronavirus by issuing stay at home orders, restricting business operations, or closing down borders as death toll in both countries approaches 600.

  • PR Newswire

    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXIM") has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. ("Sapphire").

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTCQB: KLFE) has been issued Australian Patent AU2015204609B2 (the "Patent") specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy." With this Patent, Kannalife now holds seven patents across the globe.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Becomes First Company to Legally Import CBD Products Into Russia

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has been granted Russia's first-ever certificate to legally import cannabidiol (CBD) products into the country.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio of Companies Celebrates $2 Million Milestone in CBD Product Donations to Non-Profit Organization ECHO Connection

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its portfolio of companies, including HempMeds® and Kannaway®, has officially donated $2 million in cannabidiol (CBD) products to ECHO Connection since 2017.

  • Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp + Calm CBD Oral Applicator in Europe
    PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Launches New Hemp + Calm CBD Oral Applicator in Europe

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has launched a new cannabidiol (CBD) product, its Hemp + Calm Oral Applicator, in Europe. This product is the Company's first product available in Europe that is made using its Blue Label Real Scientific Hemp Oil™ (RSHO™).

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the European Patent Office has issued European Patent EP3094318B1 (the "Patent") specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy" to its portfolio investment company Kannalife, Inc. ("Kannalife") (OTCQB: KLFE). This is the sixth patent grant that Kannalife has received.

  • HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical
    PR Newswire

    HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has launched a new high-cannabidiol (CBD) formulation of its popular Active Relief Roll-On topical product.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors Autism Event at Rice University in Houston

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored "Autism Together We Are Stronger" at Rice University on February 22.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that China has issued Chinese Patent CN106456573B (the "Patent") specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy" to its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE). The Patent strengthens Kannalife's patent portfolio of cannabidiol (CBD)-like molecules.

  • PR Newswire

    Medical Marijuana, Inc. Appoints Squar Milner LLP as New Independent Auditor

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that it has appointed Squar Milner LLP ("Squar Milner") as the Company's new independent registered public accounting firm. Squar Milner will begin work immediately on the audit of Medical Marijuana, Inc.'s December 31, 2019 consolidated balance sheet.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, has completed its phase 1 study funded by a grant (1R41DA044898-01) from the National Institutes of Health's (NIH) National Institute on Drug Abuse (NIDA).

  • PR Newswire

    Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X™ cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE), an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience.

  • Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson
    PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson, has created the world's first cannabis fitness program and is developing a new fitness-based product line to support that program.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces New Chief Medical Officer

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil has appointed Dr. Rubens Wajnsztejn as the Company's Chief Medical Officer.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway® Expands Into Russia, Kazakhstan and Kyrgyzstan

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® is now available in Russia, Kazakhstan and Kyrgyzstan.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Flagship Product Real Scientific Hemp Oil™ Featured in Us Weekly

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds®' flagship cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™) was featured in popular lifestyle outlet Us Weekly.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary Kannaway Named Most Popular CBD MLM in 2020

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has been named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list. Additionally, Kannaway® has been listed among the Top 100 MLM Companies of 2020 by Business for Home.

  • PR Newswire

    Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Opens Mexico City Office

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the opening of its subsidiary HempMeds® Mexico's new office in Mexico City.

  • PR Newswire

    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies to Acquire Leading Oncology Research and Development Company Sapphire Biotech, Inc.

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXIM") has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. ("Sapphire") as a wholly-owned subsidiary.

  • PR Newswire

    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

    Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. ("Kannalife") (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, received a designated International Nomenclature Cosmetic Ingredient (INCI) name for its patent-pending molecule and flagship consumer product to be sold under the trademark Atopidine™.

  • American Medical Association President Discusses COVID-19 Pandemic Affect on Doctors
    Yahoo Finance Video

    American Medical Association President Discusses COVID-19 Pandemic Affect on Doctors

    President of the American Medical Association, Dr. Patrice Harris speaks with Yahoo Finance's Anjalee Khemlani about the COVID-19 pandemic. Dr. Harris breaks down the stimulus package making its way through Congress as well as how the healthcare landscape will change for the future after the pandemic ends.